Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KDM5C intronic transcript 1 (KDM5C-IT1) is a long non-coding RNA (lncRNA) transcribed from within the introns of the KDM5C gene. It is not a protein-coding gene, an enzyme, or a therapeutic target (such as receptor, enzyme, transporter, etc.). There is currently no significant molecular or clinical evidence in public biomedical resources establishing KDM5C-IT1 as a functional target in disease or therapy. The KDM5C gene, by contrast, encodes a lysine-specific demethylase involved in epigenetic regulation, but KDM5C-IT1 is a distinct non-coding RNA and is not considered a direct therapeutic target[3][4][5]. If you intended to refer to the protein-coding gene KDM5C, see entries for the histone demethylase KDM5C. Otherwise, there is no evidence KDM5C-IT1 should be used as a canonical molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KDM5C intronic transcript 1 (KDM5C-IT1).